Kei Kushitani
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Merlin Immunohistochemistry Is Useful in the Differential Diagnosis of Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia.
Journal: Pathology international
Published: October 07, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C.
Journal: Cell communication and signaling : CCS
Published: September 19, 2024
Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells.
Journal: Frontiers in oncology
Published: May 17, 2024
Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma.
Journal: Anticancer research
Published: May 14, 2024
A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status That Responded to Pembrolizumab.
Journal: Case reports in oncology
Published: April 03, 2024
Reply to "Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma" by Churg et al.
Journal: The American journal of surgical pathology
Published: February 15, 2024
Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung.
Journal: Cancers
Published: November 13, 2023
SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
Journal: The American journal of surgical pathology
Published: October 30, 2023
FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling.
Journal: Anticancer research
Published: June 07, 2023
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
Journal: BMC cancer
Published: November 17, 2022
Last Updated: 09/26/2026